The NIHR Oxford Biomedical Research Centre (BRC) is to be given the Freedom of the City of Oxford. The award is the highest honour Oxford City Council can bestow and has previously been given to dignitaries including Oxfam, Nelson Mandela, authors Philip Pullman and Colin Dexter, and Sir Roger ... READ MORE
News
New imaging centre officially opened
A new Acute Multidisciplinary Imaging and Interventional Centre (AMIIC), based at the John Radcliffe Hospital, has been officially opened. AMIIC, part of the University of Oxford’s Radcliffe Department of Medicine, was previously known as AVIC (Acute Vascular Imaging Centre). The newly ... READ MORE
National guidelines produced on use of genomics in treatment of IBD
National guidelines have been developed for clinicians on the use of genomics to diagnose and care for patients with monogenic inflammatory bowel disease (IBD), a group of intestinal disorders caused by variations in a single gene. The new guidelines, unveiled in an article in the Lancet ... READ MORE
Better diagnosis and treatment of autoimmune diseases a step closer
A study involving Oxford researchers has outlined a way to find the crucial peptides (protein fragments) that drive autoimmunity, as well as the immune cells that respond to it. On a fundamental level, in autoimmune diseases immune cells mistake healthy cells for infected cells. Finding the ... READ MORE
Professor Marian Knight recognised for services to maternal and public health
Professor Marian Knight, the Oxford Biomedical Research Centre’s Co- Theme Lead for Cardiovascular Medicine, has been recognised in the New Year Honours list 2023. She was appointed Member of the Order of the British Empire (MBE) for services to Maternal and Public Health. Professor ... READ MORE
Genetic ‘marker’ linked to side-effects from skin cancer treatment found
New research has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for one of the most common skin cancers. The study, which was supported by the NIHR Oxford Biomedical Research Centre ... READ MORE
No benefit found in switching to citrate anticoagulation for ICU kidney injury treatment
New research has found no added benefit of using citrate-based drugs in the treatment of acute kidney disease in intensive care, when compared to the anticoagulation drug heparin, despite their extra cost. People with acute kidney injury (when the kidneys stop working correctly) may need a ... READ MORE
Adalimumab found to be cost-effective treatment for early-stage Dupuytren’s disease
Oxford researchers supported by the Oxford BRC have found that the anti-TNF treatment adalimumab is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease. Anti-TNF treatments interfere with the action of a protein called tumour necrosis factor (TNF) and ... READ MORE
Patient and public involvement contributors prepare for launch of new BRCs
Patient and public contributors have gathered with researchers in Oxford to discuss how patient and public involvement and engagement (PPIE) can be enhanced and play a bigger role in the new NIHR Biomedical Research Centres (BRC) when they begin next month. The workshop at St Catherine’s ... READ MORE
Oxford researcher investigates genetic mechanisms of rare forms of asthma
An Oxford researcher has been awarded funding to expand her cutting edge research into the genetic mechanisms of rare and severe forms of asthma. Dr Anastasia Fries, NIHR Academic Clinical Fellow in Respiratory Medicine, was awarded a three-year MRC Clinical Research Training Fellowship worth ... READ MORE
- 1
- 2
- 3
- …
- 76
- Next Page »